# VEON Ltd.: overview

VEON · Nasdaq · CIK 1468091 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/veon.md) · [Financials](/companies/veon/financials.md) · [Filings](/companies/veon/filings.md) · [Insiders](/companies/veon/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

Not reported.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,850](/filings/0001468091-24-000076.md) | [3,755](/filings/0001468091-25-000058.md) | [3,698](/filings/0001468091-26-000010.md) | [4,004](/filings/0001468091-26-000010.md) | [4,399](/filings/0001468091-26-000010.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [26.6%](/filings/0001468091-24-000076.md) | [31.0%](/filings/0001468091-25-000058.md) | [25.1%](/filings/0001468091-26-000010.md) | [27.7%](/filings/0001468091-26-000010.md) | [32.7%](/filings/0001468091-26-000010.md) |
| Net margin | % | [20.8%](/filings/0001468091-24-000076.md) | [(0.2%)](/filings/0001468091-25-000058.md) | [(66.3%)](/filings/0001468091-26-000010.md) | [12.2%](/filings/0001468091-26-000010.md) | [13.4%](/filings/0001468091-26-000010.md) |
| Diluted EPS | $ per share | [0.38](/filings/0001468091-24-000076.md) | [(0.09)](/filings/0001468091-25-000058.md) | [(1.44)](/filings/0001468091-26-000010.md) | [0.23](/filings/0001468091-26-000010.md) | [0.30](/filings/0001468091-26-000010.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: ifrs-full:Revenue.
- Gross margin (gross profit / revenue). XBRL Revenue: ifrs-full:Revenue.
- Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:Revenue.
- Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLoss; Revenue: ifrs-full:Revenue.
- Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare.
- Free cash flow (operating cash flow − capital expenditure). XBRL Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/veon/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Lingotto Investment Management LLP](/funds/1732768.md) | 2026-06-30 | $274.9m | 5,265,123 |  | Reduced −776,938 |
| [SHAH CAPITAL MANAGEMENT](/funds/1383838.md) | 2026-06-30 | $243.7m | 4,667,578 |  | Reduced −222,919 |
| [Solus Alternative Asset Management LP](/funds/1407737.md) | 2026-06-30 | $46.3m | 887,002 |  | Unchanged |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $40.7m | 779,077 |  | Reduced −175,449 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $39.0m | 747,852 |  | Reduced −20,269 |
| [Panview Capital Ltd](/funds/2035224.md) | 2026-06-30 | $32.9m | 630,616 |  | Added +73,004 |
| [VR Advisory Services Ltd](/funds/1348145.md) | 2026-06-30 | $31.4m | 601,205 |  | Added +207,558 |
| [Pictet Asset Management Holding SA](/funds/1993888.md) | 2026-06-30 | $14.8m | 284,145 |  | Added +122,458 |
| [MACKENZIE FINANCIAL CORP](/funds/919859.md) | 2026-06-30 | $14.3m | 273,619 |  | Added +123,177 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $10.1m | 193,950 |  | Reduced −30,456 |

## Recent filings

[All 757 filings](/companies/veon/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 12:15 ET | [6-K](/filings/0001468091-26-000038.md) | Report of a foreign private issuer, period 2026-10-20 | 0001468091-26-000038 |
| 2026-10-19 | 11:59 ET | [6-K](/filings/0001468091-26-000036.md) | Report of a foreign private issuer, period 2026-10-19 | 0001468091-26-000036 |
| 2026-10-16 | 20:15 ET | [SCHEDULE 13D/A](/filings/0001398344-26-018322.md) | Ownership report, active investor, amended | 0001398344-26-018322 |
| 2026-09-25 | 20:30 ET | [SCHEDULE 13D/A](/filings/0001193125-26-402899.md) | Ownership report, active investor, amended | 0001193125-26-402899 |
| 2026-09-23 | 13:06 ET | [6-K](/filings/0001468091-26-000034.md) | Report of a foreign private issuer, period 2026-09-23 | 0001468091-26-000034 |
| 2026-07-31 | 11:36 ET | [6-K](/filings/0001468091-26-000032.md) | Report of a foreign private issuer, period 2026-06-30 | 0001468091-26-000032 |
| 2026-07-31 | 10:10 ET | [6-K](/filings/0001468091-26-000030.md) | Report of a foreign private issuer, period 2026-06-30 | 0001468091-26-000030 |
| 2026-06-17 | 10:25 ET | [6-K](/filings/0001213900-26-069422.md) | Report of a foreign private issuer, period 2026-06-17 | 0001213900-26-069422 |
| 2026-06-02 | 12:09 ET | [6-K](/filings/0001213900-26-063800.md) | Report of a foreign private issuer, period 2026-06-02 | 0001213900-26-063800 |
| 2026-05-20 | 16:58 ET | [6-K](/filings/0001213900-26-059405.md) | Report of a foreign private issuer, period 2026-05-20 | 0001213900-26-059405 |

## Latest annual report

[Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001468091-26-000010.md), filed Mar 16, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1468091
- Tickers: VEON
- Exchange: Nasdaq
- SIC code: 4812 Radiotelephone Communications
- State of incorporation: D0
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.
